ArticleInternational journal of hematology2018

Phase I study of panobinostat and 5-azacitidine in Japanese patients with myelodysplastic syndrome or chronic myelomonocytic leukemia.

Yukio Kobayashi et al.PubMed ↗Publisher ↗

No numbers read from the abstract.